CNXC
Concentrix Corporation
CNXC's outlook is improving, though it still trails on the overall score.
NVDA
NVIDIA Corporation
NVDA has the edge over CNXC overall, supported by stronger fundamentals and stronger valuation.
CNXC Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Healthy | |
| Under pressure |
CNXC's cash flow is currently healthy, and its revenue is stable, but its profitability and balance sheet are under pressure.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
CNXC PE Valuation
CNXC has no meaningful PE right now: it lost money over the past year.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 12x next year's earnings.
CNXC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect CNXC's earnings to grow and its profitability to improve, with its revenue holding steady.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
CNXC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $11.51 | — |
| Q3 2026 | -$38.42 | -912% |
| Q2 2026 | -$20.84 | -673% |
| Q1 2026 | -$21.07 | -628% |
| Q4 2025 | -$20.36 | -649% |
| Q3 2025 | $4.73 | +57% |
| Q2 2025 | $3.64 | -14% |
| Q1 2025 | $3.99 | -17% |
| Q4 2024 | $3.71 | -35% |
CNXC has swung to a loss: it lost $38.42 per share over the past year, after a profit the year before.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over CNXC on earnings quality, reporting a profit while its opponent remains loss making.
CNXC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.5B | -1.2% |
| Q2 2026 | $2.5B | +1.9% |
| Q1 2026 | $2.5B | +5.4% |
| Q4 2025 | $2.6B | +4.3% |
| Q3 2025 | $2.5B | +4% |
| Q2 2025 | $2.4B | +1.5% |
| Q1 2025 | $2.4B | -1.3% |
| Q4 2024 | $2.4B | +9.7% |
CNXC's revenue grew through 2024 and has held roughly level since: $2.5B last quarter, down 1.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -37% | -43 points |
| Q2 2026 | 3.9% | -2.3 points |
| Q1 2026 | 4.7% | -2.4 points |
| Q4 2025 | -54% | -60 points |
| Q3 2025 | 5.9% | -0.5 points |
| Q2 2025 | 6.1% | -0.2 points |
| Q1 2025 | 7.1% | +0.9 points |
| Q4 2024 | 5.9% | -2.2 points |
CNXC's operating margin was −37% last quarter, down 43 points from the same quarter a year ago, near the bottom of its range since 2019.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over CNXC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over CNXC on profitability, with a higher operating margin.
CNXC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $221.2M | +38% |
| Q2 2026 | $209.7M | +16% |
| Q1 2026 | -$137.1M | -$87.9M |
| Q4 2025 | $281.2M | +25% |
| Q3 2025 | $159.7M | +24% |
| Q2 2025 | $180.7M | +1.4% |
| Q1 2025 | -$49.2M | +$53.7M |
| Q4 2024 | $224.5M | +37% |
CNXC generated $575M in free cash flow over the past year, up 11% from the year before.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA's free cash flow has been positive every quarter for six years: $127B over the past year, up 76% from the year before.
CNXC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +48K shares |
| 1 year | -2.9% | -1.8M shares |
| 3 years | +19% | +9.7M shares |
| 5 years | +17% | +8.8M shares |
| Available history | +19% | +9.8M shares |
CNXC has the edge over NVDA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $43.2M |
| Q4 2025 | $55.9M |
| Q3 2025 | $41.6M |
| Q2 2025 | $45.3M |
| Q1 2025 | $25.8M |
| Q4 2024 | $34.5M |
CNXC spent $99M buying back its own shares over the past year, down 33% from the year before.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has 24.3B diluted shares, down 1% from a year ago, with $55.3B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
CNXC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | 3.5x | Elevated |
| Q2 2025 | 3.5x | Elevated |
| Q1 2025 | 3.9x | Elevated |
| Q4 2024 | 4.2x | High |
| Q3 2024 | 4.7x | High |
| Q2 2024 | 5.4x | High |
| Q1 2024 | 5.6x | High |
| Q4 2023 | 5.6x | High |
CNXC's net debt is about 3.5 years of its operating earnings (EBITDA), down from 4.7 years a year ago.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
CNXC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.3 | Neutral |
| Stochastic | 68.9 | Neutral |
CNXC's weekly RSI is 56 (neutral) and its Stochastic is 69 (neutral).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
CNXC PE vs Technology Sector
| Metric | CNXC | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
CNXC has no meaningful PE right now: it lost money over the past year.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
CNXC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $28.9 | 11% above |
| 20 week MA | $27.1 | 18% above |
| 50 week MA | $30.3 | 5.7% above |
| 100 week MA | $39.7 | 19% below |
| 200 week MA | $60.0 | 47% below |
CNXC has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
CNXC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $80.0 | $99.9 | +25% |
| 2021 | $99.9 | $177.2 | +77% |
| 2022 | $177.2 | $129.6 | -27% |
| 2023 | $129.6 | $98.2 | -24% |
| 2024 | $98.2 | $44.4 | -55% |
| 2025 | $44.4 | $42.0 | -5.6% |
| 2026 YTD | $42.0 | $32.0 | -24% |
CNXC has finished four years in a row lower, and it's down 24% so far in 2026.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA has the edge over CNXC on returns for 2026, with the stronger performance.